HCSG
Healthcare Services Group, Inc.
HCSG's fundamentals are strong and it looks cheap: trading at 17x earnings, below its usual 24x. Analysts expect strong earnings growth.
HCSG Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
HCSG's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
HCSG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 17x | $25.02 | — |
| Cheap | 19x | $28.51 | +14% |
| Forward | 21x | $25.02 | — |
| Fair | 24x | $35.09 | +40% |
| Expensive | 35x | $52.32 | +109% |
Historical ranges are pointers, not guarantees.
HCSG's PE is in its cheap range at 17x. On analysts' estimates for next year's earnings, today's price would be 21x.
HCSG Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for HCSG, with profitability improving.
HCSG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.18 | -20% |
| Q3 2026 | $1.48 | +179% |
| Q2 2026 | $1.71 | +1215% |
| Q1 2026 | $0.95 | +73% |
| Q4 2025 | $0.81 | +53% |
| Q3 2025 | $0.53 | -22% |
| Q2 2025 | $0.13 | -69% |
| Q1 2025 | $0.55 | -1.8% |
| Q4 2024 | $0.53 | +1.9% |
HCSG earned $1.48 per share over the past year, up 179% from the year before.
HCSG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $479.6M | +3.3% |
| Q2 2026 | $470.8M | +2.7% |
| Q1 2026 | $462.8M | +3.4% |
| Q4 2025 | $466.7M | +6.6% |
| Q3 2025 | $464.3M | +8.5% |
| Q2 2025 | $458.5M | +7.6% |
| Q1 2025 | $447.7M | +5.7% |
| Q4 2024 | $437.8M | +3.3% |
HCSG's revenue has grown year over year for 11 quarters in a row: $480M last quarter, up 3.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7% | -5.3 points |
| Q2 2026 | 6.6% | +16 points |
| Q1 2026 | 7.5% | +2.1 points |
| Q4 2025 | 6.1% | +2.7 points |
| Q3 2025 | 12% | +8 points |
| Q2 2025 | -9.1% | -8.7 points |
| Q1 2025 | 5.3% | +0.3 points |
| Q4 2024 | 3.4% | -3.9 points |
HCSG's operating margin was 7% last quarter, down 5.3 points from the same quarter a year ago.
HCSG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $28.1M | -60% |
| Q2 2026 | $20.2M | -26% |
| Q1 2026 | $42.3M | +64% |
| Q4 2025 | $16M | -54% |
| Q3 2025 | $70M | +2302% |
| Q2 2025 | $27.4M | +83% |
| Q1 2025 | $25.8M | +$54M |
| Q4 2024 | $34.8M | -28% |
HCSG still generates free cash flow, though less than at its 2020 peak: $107M over the past year.
HCSG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -526K shares |
| 1 year | -4.9% | -3.6M shares |
| 3 years | -6.7% | -5M shares |
| 5 years | -7.6% | -5.7M shares |
| Available history | -7% | -5.2M shares |
HCSG has 69M diluted shares, down 4.9% from a year ago, with $76M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $11.7M |
| Q2 2026 | $20.9M |
| Q1 2026 | $24M |
| Q4 2025 | $19.6M |
| Q3 2025 | $27.3M |
| Q2 2025 | $7.7M |
| Q1 2025 | $7M |
| Q4 2024 | $1M |
HCSG spent $76M buying back its own shares over the past year, up 77% from the year before.
HCSG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.9x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -1.4x | Net Cash |
| Q4 2025 | -1.5x | Net Cash |
| Q3 2025 | -1.8x | Net Cash |
| Q2 2025 | -2.6x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -0.5x | Net Cash |
HCSG has more cash than debt.
HCSG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.1 | Neutral |
| Stochastic | 70.5 | Neutral |
HCSG's weekly RSI is 61 (neutral) and its Stochastic is 71 (neutral).
HCSG PE vs Healthcare Sector
| Metric | HCSG | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 26x | 35% below |
| PE % | 6 | 29 | 23 pts below |
HCSG is trading at 17x earnings, a 35% discount to the Healthcare sector's median of 26x.
HCSG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $22.9 | 9.5% above |
| 20 week MA | $22.9 | 9.4% above |
| 50 week MA | $21.3 | 17% above |
| 100 week MA | $17.5 | 43% above |
| 200 week MA | $14.7 | 71% above |
HCSG is in an uptrend: it's above all five of its weekly moving averages, and 71% above its 200-week average.
HCSG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $24.3 | $27.1 | +11% |
| 2021 | $27.1 | $17.2 | -37% |
| 2022 | $17.2 | $12.2 | -29% |
| 2023 | $12.2 | $10.4 | -15% |
| 2024 | $10.4 | $11.5 | +11% |
| 2025 | $11.5 | $19.6 | +70% |
| 2026 YTD | $19.6 | $25.0 | +27% |
HCSG has finished lower in three of the last six years. It's up 27% so far in 2026.